Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein
Ochoa MC, Fioravanti J, Rodriguez I, Hervas-Stubbs S, Azpilikueta A, Mazzolini G, Gurpide A, Prieto J, Pardo J, Berraondo P* and Melero I* (*similar contribution). Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. Cancer Research. 2013; 73(1):139-49 1
Factor de impacto:
7,86